• Explore /
  • Poster
  • / A phase I trial of chemoimmunotherapy combining bacillus Calmette-Guerin (BCG) and intravesical gemcitabine for patients with BCG-relapsing high-grade nonmuscle-invasive bladder cancer.

A phase I trial of chemoimmunotherapy combining bacillus Calmette-Guerin (BCG) and intravesical gemcitabine for patients with BCG-relapsing high-grade nonmuscle-invasive bladder cancer.

Abstract Poster

Authors

null

Manuel R. De Jesus Escano

Memorial Sloan Kettering Cancer Center, New York, NY

Manuel R. De Jesus Escano , Daniel D. Sjoberg , Melissa McCarter , Marlena McGill , Alvin Goh , Timothy F. Donahue , S. Machele Donat , Eugene K. Cha , Harry W. Herr , Anoop M. Meraney , Hikmat A Al-Ahmadie , David B. Solit , Guido Dalbagni , Dean F. Bajorin , Bernard H. Bochner , Eugene J. Pietzak

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2021 Genitourinary Cancers Symposium

Session Type

Trials in Progress Poster Session

Session Title

Trials in Progress Poster Session: Urothelial Carcinoma

Track

Urothelial Carcinoma

Sub Track

Therapeutics

Clinical Trial Registration Number

NCT04179162

Citation

J Clin Oncol 39, 2021 (suppl 6; abstr TPS509)

DOI

10.1200/JCO.2021.39.6_suppl.TPS509

Abstract #

TPS509

Poster Bd #

Online Only

Abstract Disclosures

Similar Posters

First Author: Christopher Gaffney

First Author: Guarionex Joel DeCastro

First Author: Gary D. Steinberg

First Author: Anosh Dadabhoy